Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2

Lisi, L., Lacal, P. M., Barbaccia, M. L., & Graziani, G. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114169 · Cited by 42

COVID‐19 and education: restructuring after the pandemic

Bellini, M. I., Pengel, L. H. M., Potena, L., Segantini, L., & ESOT COVID‐19 Working Group (2020) · Transplant International · doi:10.1111/tri.13788 · Cited by 40

COVID-19 Pandemic and Children: A Review

Rathore, V., Galhotra, A., Pal, R., & Sahu, K. K. (2020) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-25.7.574 · Cited by 39

COVID-19 survey burden for health care workers: literature review and audit

Gnanapragasam, S., Hodson, A., Smith, L., Greenberg, N. L., Rubin, G. J., & Wessely, S. C. (2021) · Public Health · doi:10.1016/j.puhe.2021.05.006 · Cited by 39

Preprints

Puebla, I., Polka, J., & Rieger, O. Y. (2022) · doi:10.3998/mpub.12412508 · Cited by 45

Science and Ethics of “Curing” Misinformation

Freiling, I., Krause, N. M., & Scheufele, D. A. (2023) · The AMA Journal of Ethic · doi:10.1001/amajethics.2023.228 · Cited by 39

Pathogenesis of SARS-CoV-2 induced cardiac injury from the perspective of the virus

Knowlton, K. U. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.08.002 · Cited by 39

Pathomechanisms and Clinical Implications of Myasthenic Syndromes Exacerbated and Induced by Medical Treatments

Krenn, M., Grisold, A., Wohlfarth, P., Rath, J., Çetin, H., Koneczny, I., & Zimprich, F. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00156 · Cited by 38

Frauds in scientific research and how to possibly overcome them

Boetto, E., Golinelli, D., Carullo, G., & Fantini, M. P. (2020) · Journal of Medical Ethics · doi:10.1136/medethics-2020-106639 · Cited by 38

Hydroxychloroquine for COVID19: the curtains close on a comedy of errors

Schwartz, I. S., Boulware, D. R., & Lee, T. C. (2022) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2022.100268 · Cited by 37

A data-driven approach to identify risk profiles and protective drugs in COVID-19

Cippà, P. E., Cugnata, F., Ferrari, P., Brombin, C., Ruinelli, L., Bianchi, G., Beria, N., Schulz, L., Bernasconi, E., Merlani, P. G., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2016877118 · Cited by 39

CORDITE: The Curated CORona Drug InTERactions Database for SARS-CoV-2

Martin, R., Löchel, H. F., Welzel, M., Hattab, G., Hauschild, A.-C., & Heider, D. (2020) · iScience · doi:10.1016/j.isci.2020.101297 · Cited by 37

Predicting mortality of individual patients with COVID-19: a multicentre Dutch cohort

Ottenhoff, M. C., Ramos, L. A., Potters, W. V., Janssen, M. L. F., Hubers, D., Piña‐Fuentes, D., Thomas, R. M., van der Horst, I. C. C., Herff, C., Kubben, P., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-047347 · Cited by 37

Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19

Albani, F., Fusina, F., Giovannini, A., Ferretti, P., Granato, A., Prezioso, C., Divizia, D., Sabaini, A., Marri, M., Malpetti, E., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092800 · Cited by 37

Research Output and International Cooperation Among Countries During the COVID-19 Pandemic: Scientometric Analysis

Grammes, N. L., Millenaar, D., Fehlmann, T., Kern, F., Böhm, M., Mahfoud, F., & Keller, A. (2020) · Journal of Medical Internet Research · doi:10.2196/24514 · Cited by 36

Drugs that offer the potential to reduce hospitalization and mortality from SARS-CoV-2 infection: The possible role of the sigma-1 receptor and autophagy

Brimson, J. M., Prasanth, M. I., Malar, D. S., Brimson, S., Thitilertdecha, P., & Tencomnao, T. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1952987 · Cited by 36

Reduced COVID-19 Mortality With Sitagliptin Treatment? Weighing the Dissemination of Potentially Lifesaving Findings Against the Assurance of High Scientific Standards

Nauck, M. A., & Meier, J. J. (2020) · Diabetes Care · doi:10.2337/dci20-0062 · Cited by 34

Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: A multicentre retrospective study

Sarzi‐Puttini, P., Marotto, D., Caporali, R. F., Montecucco, C., Favalli, E. G., Franceschini, F., Fredi, M., Balduzzi, S., Bazzani, C., Bongiovanni, S. F., et al. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102545 · Cited by 33

Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine

Stevens, D. M., Crist, R. M., & Stern, S. T. (2020) · Molecules · doi:10.3390/molecules26010175 · Cited by 33

Prediction models for severe manifestations and mortality due to COVID ‐19: A systematic review

Miller, J. L., Tada, M., Goto, M., Chen, H., Dang, E., Mohr, N. M., & Lee, S. (2022) · Academic Emergency Medicine · doi:10.1111/acem.14447 · Cited by 35

Academic Integrity Perceptions Among Health-Professions’ Students: A Cross-Sectional Study in The Middle East

Kadayam Guruswami, G., Mumtaz, S., Gopakumar, A., Khan, E., Abdullah, F., & Parahoo, S. K. (2023) · Journal of Academic Ethics · doi:10.1007/s10805-022-09452-6 · Cited by 31

Inference of COVID-19 epidemiological distributions from Brazilian hospital data

Hawryluk, I., Mellan, T. A., Hoeltgebaum, H., Mishra, S., Schnekenberg, R. P., Whittaker, C., Zhu, H., Gandy, A., Donnelly, C. A., Flaxman, S. R., et al. (2020) · Journal of The Royal Society Interface · doi:10.1098/rsif.2020.0596 · Cited by 30

Versioning Data Is About More than Revisions: A Conceptual Framework and Proposed Principles

Klump, J., Wyborn, L., Wu, M., Martín, J. A. R. S., Downs, R. R., & Asmi, A. (2021) · Data Science Journal · doi:10.5334/dsj-2021-012 · Cited by 30

App-based symptom tracking to optimize SARS-CoV-2 testing strategy using machine learning

Dantas, L. F., Peres, I. T., Bastos, L. D. S. L., Marchesi, J. F., Souza, G., Gelli, J. G. M., Baião, F., Maçaira, P., Hamacher, S., & Bozza, F. A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248920 · Cited by 31

Publications and retracted articles of COVID-19 pharmacotherapy-related research: A systematic review

El-Menyar, A. A., Mekkodathil, A. A., Asim, M., Consunji, R. J., Rizoli, S. B., Bahey, A. A., & Al-Thani, H. A. S. (2021) · Science Progress · doi:10.1177/00368504211016936 · Cited by 33

Thinking critically through controversial issues on digital media: Dispositions and key criteria for content evaluation

Meneses, L. F. S. (2021) · Thinking Skills and Creativity · doi:10.1016/j.tsc.2021.100927 · Cited by 35

Can tweets be used to detect problems early with scientific papers? A case study of three retracted COVID-19/SARS-CoV-2 papers

Haunschild, R., & Bornmann, L. (2021) · Scientometrics · doi:10.1007/s11192-021-03962-7 · Cited by 29

Challenges and Controversies in Peer Review

Kusumoto, F. M., Bittl, J. A., Creager, M. A., Dauerman, H. L., Lala, A., McDermott, M. M., Turco, J. V., Taqueti, V. R., & Fuster, V. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.08.056 · Cited by 34

Current Scenario and Future Prospect in the Management of COVID-19

Borah, P., Deb, P. K., Deka, S., Venugopala, K. N., Singh, V., Mailavaram, R. P., Kalia, K., & Tekade, R. K. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200908113642 · Cited by 29

Chloroquine, hydroxychloroquine, and COVID-19: Systematic review and narrative synthesis of efficacy and safety

Takla, M., & Jeevaratnam, K. (2020) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2020.11.003 · Cited by 30

Characteristics and Risk Factors Associated With Mortality in a Multicenter Spanish Cohort of Patients With COVID-19 Pneumonia

Muñoz‐Rodríguez, J. R., Romero, F. J. G., Pérez‐Ortiz, J. M., López-Juárez, P., Santiago, J. L., Serrano‐Oviedo, L., & Calvo, F. J. R. (2021) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2021.02.021 · Cited by 29

Hydroxychloroquine with or without azithromycin and in-hospital mortality or discharge in patients hospitalized for COVID-19 infection: a cohort study of 4,642 in-patients in FrancePreprint

Sbidian, É., Josse, J., Lemaitre, G., Meyer, I., Bernaux, M., Gramfort, A., Lapidus, N., Paris, N., Neuraz, A., Lerner, I., et al. (2020) · medRxiv · doi:10.1101/2020.06.16.20132597 · Cited by 31

Upcoming and urgent challenges in critical care research based on COVID-19 pandemic experience

Verdonk, F., Feyaerts, D., Badenes, R., Bastarache, J. A., Bouglé, A., Ely, W., Gaudilliere, B. L., Howard, C., Kotfis, K., Lautrette, A., et al. (2022) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2022.101121 · Cited by 29

Coronavirus disease 2019 (COVID-19): latest developments in potential treatments

Hon, K. E., Leung, K. K. Y., Leung, A. K. C., Qian, S. Y., Chan, V. P. Y., Ip, P., & Wong, I. C. K. (2020) · Drugs in Context · doi:10.7573/dic.2020-4-15 · Cited by 28

Management of SARS‐CoV‐2 pneumonia

Sagnelli, C., Celia, B., Monari, C., Cirillo, S., Angelis, G. D., Bianco, A., & Coppola, N. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26470 · Cited by 29

Removal of Remdesivir’s Metabolite GS-441524 by Hemodialysis in a Double Lung Transplant Recipient with COVID-19

Lê, M., Hingrat, Q. L., Jaquet, P., Wicky, P.-H., Bunel, V., Massias, L., Visseaux, B., Messika, J., Descamps, D., Mal, H., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01521-20 · Cited by 28

Hydroxychloroquine for the treatment and prophylaxis of COVID-19: The journey so far and the road ahead

Singh, H., Chauhan, P., & Kakkar, A. K. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173717 · Cited by 28

Repurposing Chloroquine Against Multiple Diseases With Special Attention to SARS-CoV-2 and Associated Toxicity

Kamat, S., & Kumari, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.576093 · Cited by 29

Predatory Journals and Meetings in Forensic Sciences: What Every Expert Needs to Know about This “Parasitic” Publishing Model

Dinis‐Oliveira, R. J. (2021) · Forensic Sciences Research · doi:10.1080/20961790.2021.1989548 · Cited by 28

Antiviral treatment of COVID-19: a clinical pharmacology narrative review

Instiaty, Darmayani, I. G. A. A. P. S., Marzuki, J. E., Angelia, F., William, Siane, A., Sary, L. D., Yohanes, L., Widyastuti, R., Nova, R., et al. (2020) · Medical Journal of Indonesia · doi:10.13181/mji.rev.204652 · Cited by 27

Favipiravir use for SARS CoV-2 infection

Boretti, A. A. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00175-2 · Cited by 27

Risk of COVID-19 hospital admission and COVID-19 mortality during the first COVID-19 wave with a special emphasis on ethnic minorities: an observational study of a single, deprived, multiethnic UK health economy

Singh, B. M., Bateman, J., Viswanath, A., Klaire, V., Mahmud, S. A. S., Nevill, A. M., & Dunmore, S. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-046556 · Cited by 27

Hydroxychloroquine use in COVID-19: is the risk of cardiovascular toxicity justified?

Stevenson, A., Kirresh, A. Z., Conway, S., White, L., Ahmad, M., & Little, C. D. (2020) · Open Heart · doi:10.1136/openhrt-2020-001362 · Cited by 27

Chloroquine and hydroxychloroquine for COVID‐19: Perspectives on their failure in repurposing

Shah, R. R. (2020) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13267 · Cited by 26

N-Glycan Modification in Covid-19 Pathophysiology: In vitro Structural Changes with Limited Functional Effects

Nunes-Santos, C. J., Kuehn, H. S., & Rosenzweig, S. D. (2020) · Journal of Clinical Immunology · doi:10.1007/s10875-020-00905-4 · Cited by 26

How the scientific community responded to the COVID-19 pandemic: A subject-level time-trend bibliometric analysis

Malekpour, M., Abbasi‐Kangevari, M., Azadnajafabad, S., Ghamari, S., Rezaei, N., Rezazadeh-Khadem, S., Rezaei, N., Aminorroaya, A., Abdolhamidi, E., Fateh, S. M., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258064 · Cited by 26

Zinc(II)—The Overlooked Éminence Grise of Chloroquine’s Fight against COVID-19?

Hecel, A., Ostrowska, M., Stokowa‐Sołtys, K., Wątły, J., Dudek, D., Miller, A., Potocki, S., Matera-Witkiewicz, A., Domínguez‐Martín, A., Kozłowski, H., et al. (2020) · Pharmaceuticals · doi:10.3390/ph13090228 · Cited by 25

Identification and Development of Therapeutics for COVID-19

Rando, H. M., Wellhausen, N., Ghosh, S., Lee, A. J., Dattoli, A. A., Hu, F., Byrd, J. B., Rafizadeh, D. N., Lordan, R., Qi, Y., et al. (2021) · mSystems · doi:10.1128/msystems.00233-21 · Cited by 25

The COVID-19 (SARS-CoV-2) uncertainty tripod in Brazil: Assessments on model-based predictions with large under-reporting

Bastos, S. B., Morato, M. M., Cajueiro, D. O., & Normey-Rico, J. E. (2021) · Alexandria Engineering Journal · doi:10.1016/j.aej.2021.03.004 · Cited by 25

Healthcare Data Management by Using Blockchain Technology

Bittins, S., Kober, G., Margheri, A., Masi, M., Miladi, A., & Vladimiro Sassone, C. (2020) · Studies in big data · doi:10.1007/978-981-15-9547-9_1 · Cited by 25

Repurposing Existing Drugs for the Treatment of COVID-19

Farne, H. A., Kumar, K., Ritchie, A. I., Finney, L., Johnston, S. L., & Singanayagam, A. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202005-566fr · Cited by 24

Toward in vivo-relevant hERG safety assessment and mitigation strategies based on relationships between non-equilibrium blocker binding, three-dimensional channel-blocker interactions, dynamic occupancy, dynamic exposure, and cellular arrhythmia

Wan, H., Selvaggio, G., & Pearlstein, R. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234946 · Cited by 24

Contested effects and chaotic policies: the 2020 story of (hydroxy) chloroquine for treating COVID-19

Gould, S., & Norris, S. L. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.ed000151 · Cited by 24

Hydroxychloroquine and mortality in COVID-19 patients: a systematic review and a meta-analysis of observational studies and randomized controlled trials

Castelnuovo, A. F. D., Costanzo, S., Cassone, A., Cauda, R., de Gaetano, G., & Iacoviello, L. (2021) · Pathogens and Global Health · doi:10.1080/20477724.2021.1936818 · Cited by 24

Safety perspectives on presently considered drugs for the treatment of COVID‐19

Penman, S. L., Kiy, R. T., Jensen, R. L., Betts, C. B., Alfirevic, A., Back, D. J., Khoo, S., Owen, A., Pirmohamed, M., Park, B. K., et al. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15204 · Cited by 24

Reimagining the peer‐review system for translational health science journals

Smith, E. M. R. (2021) · Clinical and Translational Science · doi:10.1111/cts.13050 · Cited by 27

Wound care during the COVID-19 pandemic: improving outcomes through the integration of telemedicine

Oropallo, A., Lantis, J. C., Martin, A. M., Rubaiay, A. A., & Wang, N. (2021) · Journal of Wound Care · doi:10.12968/jowc.2021.30.sup2.s12 · Cited by 26

Versioning biological cells for trustworthy cell engineering

Tellechea‐Luzardo, J., Hobbs, L., Velázquez, E., Pelechova, L., Woods, S., de Lorenzo, V., & Krasnogor, N. (2022) · Nature Communications · doi:10.1038/s41467-022-28350-4 · Cited by 23

Cardiovascular Safety of Hydroxychloroquine in US Veterans With Rheumatoid Arthritis

Faselis, C. J., Zeng‐Treitler, Q., Cheng, Y., Kerr, G. S., Nashel, D. J., Liappis, A. P., Weintrob, A., Karasik, P., Arundel, C., Boehm, D., et al. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41803 · Cited by 23

The protective role of vitamin C in the management of COVID-19: A Review

Uddin, M. S., Millat, M. S., Baral, P. K., Ferdous, M., Uddin, M. G., Sarwar, M. S., & Islam, M. S. (2021) · Journal of the Egyptian Public Health Association · doi:10.1186/s42506-021-00095-w · Cited by 24

Access to data from clinical trials in the COVID-19 crisis: open, flexible, and time-sensitive

Ewers, M., Ioannidis, J. P. A., & Plesnila, N. (2020) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2020.10.008 · Cited by 24

Randomised controlled trials for COVID-19: evaluation of optimal randomisation methodologies—need for data validation of the completed trials and to improve ongoing and future randomised trial designs

Emani, V. R., Goswami, S., Nandanoor, D., Emani, S. R., Reddy, N. K., & Reddy, R. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106222 · Cited by 24

Publication Rate and Journal Review Time of COVID-19–Related Research

Putman, M., Ruderman, E., & Niforatos, J. D. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.08.017 · Cited by 22

Hydroxychloroquine, COVID ‐19 and diabetes. Why it is a different story

Stoian, A. P., Catrinoiu, D., Rizzo, M., & Ceriello, A. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3379 · Cited by 21

Repurposing drugs as COVID-19 therapies: A toxicity evaluation

Ngan, D. K., Xu, T., Xia, M., Zheng, W., & Huang, R. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.04.001 · Cited by 21

#Covid4Rheum: an analytical twitter study in the time of the COVID-19 pandemic

Ruffer, N., Knitza, J., & Krusche, M. (2020) · Rheumatology International · doi:10.1007/s00296-020-04710-5 · Cited by 21

SARS-CoV-2 (COVID-19) en pacientes con algún grado de inmunosupresión

Cajamarca-Barón, J., Guavita-Navarro, D., Buitrago-Bohórquez, J., Gallego-Cardona, L., Navas, Á., Cubides, H. H., Arredondo, A. M., Escobar, A., & Rojas‐Villarraga, A. (2020) · Reumatología Clínica · doi:10.1016/j.reuma.2020.08.004 · Cited by 21

The Network That Never Sleeps

Mukhopadhyay, S., Kanakis, C. E., Golab, K., Hermelin, D., Crane, G. M., & Mirza, K. (2020) · Laboratory Medicine · doi:10.1093/labmed/lmaa113 · Cited by 21

Clinical Research in Hepatology in the COVID‐19 Pandemic and Post‐Pandemic Era: Challenges and the Need for Innovation

Verna, E. C., Serper, M., Chu, J., Corey, K. E., Fix, O. K., Hoyt, K., Page, K. A., Loomba, R. S., Li, M., Everson, G. T., et al. (2020) · Hepatology · doi:10.1002/hep.31491 · Cited by 20

Open knowledge commons versus privatized gain in a fractured information ecology: lessons from COVID-19 for the future of sustainability

Hensher, M., Kish, K., Farley, J., Quilley, S., & Zywert, K. (2020) · Global Sustainability · doi:10.1017/sus.2020.21 · Cited by 20

Socioeconomic position and adverse childhood experiences as risk factors for health-related behaviour change and employment adversity during the COVID-19 pandemic: insights from a prospective cohort study in the UK

Smith, M. L., Herbert, A., Hughes, A., Northstone, K., & Howe, L. D. (2022) · BMC Public Health · doi:10.1186/s12889-022-14184-8 · Cited by 20

COVID ‐19 and the generation of novel scientific knowledge: Evidence‐based decisions and data sharing

Perillat, L., & Baigrie, B. S. (2021) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.13548 · Cited by 23

Fraud and retraction in perioperative medicine publications: what we learned and what can be implemented to prevent future recurrence

Nato, C. G., Tabacco, L., & Bilotta, F. (2021) · Journal of Medical Ethics · doi:10.1136/medethics-2021-107252 · Cited by 20

Retractions and post-retraction citations in the COVID-19 infodemic

Santos-d’Amorim, K., de Melo, R. R., & dos Santos, R. N. M. (2021) · Liinc em Revista · doi:10.18617/liinc.v17i1.5593 · Cited by 20

An analysis of retractions in neurosurgery and allied clinical and basic science specialties

Madhugiri, V. S., Nagella, A. B., & Uppar, A. M. (2021) · Acta Neurochirurgica · doi:10.1007/s00701-020-04615-z · Cited by 19

Hospital Preparedness for COVID-19: The Known and The Known Unknown

Kaito, D., Matsumura, K., & Yamamoto, R. (2020) · The Keio Journal of Medicine · doi:10.2302/kjm.2020-0011-oa · Cited by 20

Modelling palliative and end-of-life resource requirements during COVID-19: implications for quality care

Chalk, D., Robbins, S., Kandasamy, R., Rush, K., Aggarwal, A. K., Sullivan, R. J., & Chamberlain, C. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-043795 · Cited by 19

Pandemic politics—lessons for solar geoengineering

Buck, H. J., Geden, O., Sugiyama, M., & Corry, O. (2020) · Communications Earth & Environment · doi:10.1038/s43247-020-00018-1 · Cited by 20

Insights on the Evidence of Cardiotoxicity of Hydroxychloroquine Prior and During COVID‐19 Epidemic

Romani, S., Gérard, A. O., Fresse, A., Viard, D., Obberghen, E. K. V., Micallef, J., Rocher, F., Drici, M., & the French Pharmacovigilance Network (2020) · Clinical and Translational Science · doi:10.1111/cts.12883 · Cited by 19

Open science and conflict of interest policies of medical and health sciences journals before and during the COVID-19 pandemic: A repeat cross-sectional study

Gardener, A. D., Hick, E. J., Jacklin, C., Tan, G., Cashin, A. G., Lee, H., Nunan, D., Toomey, E. C., & Richards, G. C. (2022) · JRSM Open · doi:10.1177/20542704221132139 · Cited by 22

Retraction of COVID-19 Pharmacoepidemiology Research Could Have Been Avoided by Effective Use of Reporting Guidelines

Benchimol, E. I., Moher, D., Ehrenstein, V., & Langan, S. (2020) · Clinical Epidemiology · doi:10.2147/clep.s288677 · Cited by 19

COVİD-19 PANDEMİSİ ve KADINLAR

Ünal, E., Atik, D., & Gözüyeşil, E. (2020) · Haliç Üniversitesi Sağlık Bilimleri Dergisi · doi:10.48124/husagbilder.825346 · Cited by 19

Raising concerns on questionable ethics approvals – a case study of 456 trials from the Institut Hospitalo-Universitaire Méditerranée Infection

Frank, F., Florens, N., Meyerowitz‐Katz, G., Barrière, J., Billy, É., Saada, V., Samuel, A., Robert, J., & Besançon, L. (2023) · Research Integrity and Peer Review · doi:10.1186/s41073-023-00134-4 · Cited by 18

Benefits and obstacles to cell therapy in neonates: The INCuBAToR (Innovative Neonatal Cellular Therapy for Bronchopulmonary Dysplasia: Accelerating Translation of Research)

Thébaud, B., Lalu, M. M., Renesme, L., van Katwyk, S., Presseau, J., Thavorn, K., Cobey, K. D., Hutton, B., Moher, D., Soll, R. F., et al. (2021) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0508 · Cited by 18

The mass production of systematic reviews about COVID‐19: An analysis of PROSPERO records

Dotto, L., Kinalski, M. D. A., Machado, P. S., Pereira, G. K. R., Sarkis‐Onofre, R., & dos Santos, M. B. F. (2021) · Journal of Evidence-Based Medicine · doi:10.1111/jebm.12426 · Cited by 18

Pathophysiological metabolic changes associated with disease modify the proarrhythmic risk profile of drugs with potential to prolong repolarisation

TeBay, C., McArthur, J. R., Mangala, M. M., Kerr, N. P., Heitmann, S., Perry, M., Windley, M. J., Vandenberg, J. I., & Hill, A. P. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15757 · Cited by 18

Association between environmental pollution and prevalence of coronavirus disease 2019 (COVID-19) in ItalyPreprint

Lippi, G., Sanchis‐Gomar, F., & Henry, B. M. (2020) · medRxiv · doi:10.1101/2020.04.22.20075986 · Cited by 18

Tribal Truce — How Can We Bridge the Partisan Divide and Conquer Covid?

Rosenbaum, L. R. (2020) · New England Journal of Medicine · doi:10.1056/nejmms2027985 · Cited by 18

Hydroxychloroquine use and progression or prognosis of COVID-19: a systematic review and meta-analysis

Zang, Y., Han, X., He, M., Shi, J. C., & Li, Y. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01964-5 · Cited by 17

Severity and Mortality Associated with Steroid Use among Patients with COVID-19: A Systematic Review and Meta-Analysis

Sahilu, T., Sheleme, T., & Melaku, T. (2021) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2021/6650469 · Cited by 17

Reasons and implications of retracted articles in Brazil

Santos-d’Amorim, K., Correia, A. E. G. C., Miranda, M. K. F. D. O., & Santa‐Cruz, P. A. (2021) · Transinformação · doi:10.1590/2318-0889202133e210001 · Cited by 18

Characteristics of global retractions of schizophrenia-related publications: A bibliometric analysis

Chen, P., Li, X.-H., Su, Z., Tang, Y., Ma, Y., Ng, C. H., & Xiang, Y. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.937330 · Cited by 16

Preprints in Medicine: Useful or Harmful?

Bonnechère, B. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.579100 · Cited by 16

Clinical characteristics of older patients with COVID-19: a systematic review of case reports

Córdova, L. D. S., Mayor-Vega, A., Luján-Carpio, E., Parodi, J. F., Moncada–Mapelli, E., Armacanqui-Valencia, I., Salvador-Ruiz, J., Pawer, D., Ydrogo-Cruz, E., Chevarría-Arriaga, M. J., et al. (2021) · Dementia & Neuropsychologia · doi:10.1590/1980-57642021dn15-010001 · Cited by 16

The Global Regulation of “Fake News” in the Time of Oxymora: Facts and Fictions about the Covid-19 Pandemic as Coincidences or Predictive Programming?

Neuwirth, R. J. (2021) · International Journal for the Semiotics of Law - Revue internationale de Sémiotique juridique · doi:10.1007/s11196-021-09840-y · Cited by 16

Rapid Workforce Development to Combat the COVID-19 Pandemic: Experience From a Tertiary Health Care Centre in North India

Rao, S., Rohilla, K. K., Kathrotia, R., Naithani, M., Varghese, A., Bahadur, A., Dhar, P., Aggarwal, P., Gupta, M., & Kant, R. (2021) · Cureus · doi:10.7759/cureus.15585 · Cited by 16

Ongoing Citations of a Retracted Study Involving Cardiovascular Disease, Drug Therapy, and Mortality in COVID-19

Lee, T. C., Senécal, J., Hsu, J. M.-Y., & McDonald, E. G. (2021) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2021.4112 · Cited by 16

Research integrity during the COVID-19 pandemic: Perspectives of health science researchers at an Academic Health Science Center

Smith, E. M. R., Rakestraw, C., & Farroni, J. S. (2022) · Accountability in Research · doi:10.1080/08989621.2022.2029704 · Cited by 16

COVID-19 pandemic is not the time of trial and error

Mohamed, K., & Rezaei, N. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.09.020 · Cited by 15

Pharmacological management of COVID-19 in type 2 diabetes

Ceriello, A., & Prattichizzo, F. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.107927 · Cited by 15

On the Importance of Data Transparency

Callaghan, S. (2020) · Patterns · doi:10.1016/j.patter.2020.100070 · Cited by 6

News in Brief

Passi, G. R. (2020) · Indian Pediatrics · doi:10.1007/s13312-020-1908-5

Learning from a retraction

The Editors of the Lancet Group (2020) · The Lancet · doi:10.1016/s0140-6736(20)31958-9 · Cited by 50

Data from Mehra et al. (2020-05-29), "Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis"

Mehra, M. R., Desai, S. S., Ruschitzka, F. T., & Patel, A. N. (2020) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.3870966

Zweifelhafte COVID-Studien – die Grenzen des Peer Reviews und der Nutzen von Twitter

Nößler, D., & Scherer, M. (2020) · EvidenzUpdate · doi:10.69156/pod.001/2020.06.00035